 Measuring intellectual capital and sources of equity financing – value platform perspective within the Finnish biopharmaceutical industryRaine Hermans and Martti Kulvik International Journal of Learning and Intellectual Capital, 2004, vol. 1, issue 3, 282-303 Abstract: The aim of this study is to create a theoretically derived basis for measuring intellectual capital within the Finnish biopharmaceutical industry, and to relate these measures to ownership structures. Our empirical model employs survey data from small and medium-sized Finnish biopharmaceutical companies. The sources of equity financing are identified and the means of measuring Intellectual Capital (IC) in the value platform framework is created. Various sources of financing are related to the intellectual capital and other characteristic features of these companies. The biotechnology company owned by another firm is distinctive, corresponding to different strategic functions designated to the company by the owner firm. The largest investor group, venture capital companies, seem to prefer a well-balanced combination of intellectual capital. The other owner groups showed among themselves a rather similar pattern of investment preferences. Keywords: biotechnology; capital structure; intellectual capital; knowledge management; measurement; biopharmaceutical industry; Finland; equity financing; investment preferences. (search for similar items in EconPapers) Downloads: (external link) Related works: Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text Persistent link: https://EconPapers.repec.org/RePEc:ids:ijlica:v:1:y:2004:i:3:p:282-303 Access Statistics for this article More articles in International Journal of Learning and Intellectual Capital from Inderscience Enterprises Ltd |
Is your work missing from RePEc? Here is how to contribute.
Questions or problems? Check the EconPapers FAQ or send mail to .
EconPapers is hosted by the
School of Business at Örebro University.